Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Kitron Board/Management Information 2019

Jan 3, 2019

3643_rns_2019-01-03_370810fb-1257-4948-a831-3a428d6f70b4.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Kitron CEO Peter Nilsson on medical leave

Kitron CEO Peter Nilsson on medical leave

(2019-01-03) Kitron ASA's President and Chief Executive Officer Peter Nilsson

will be undergoing treatment for a type of cancer and is expected to be on leave

of absence until the end of June 2019, after which he will resume his duties.

Effective today, Chief Financial Officer Cathrin Nylander will be acting

President and Chief Executive Officer. Ms. Nylander has been the CFO of Kitron

since August 2013.

"The board wishes Peter a speedy recovery and look forward to his return in the

summer. In the meantime, we know that Cathrin and the rest of the management

team will do an excellent job implementing the ambitious plans for 2019," said

Tuomo Lähdesmäki, Chairman of the Board of Kitron ASA.

For further information, please contact:

Tuomo Lähdesmäki, Chairman of the Board, tel: +358 50 5879648

Cathrin Nylander, Acting President and CEO, tel: +47 900 43 284

E-mail: [email protected]

Kitron is one of Scandinavia's leading electronics manufacturing services

companies for the Energy/Telecoms, Industry, Defence, Medical devices and

Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania,

Germany, China and the United States. Kitron had revenues of approx. NOK 2.4

billion in 2017 and has about 1,450 employees. www.kitron.com

This information is subject to the disclosure requirements set out in section 5

-12 of the Norwegian Securities Trading Act, and section 3-4 of the Oslo Stock

Exchange continuing obligations for listed companies.